How do you successfully use existing registries to generate impactful evidence? This article breaks down the three key ingredients to the successful creation of evidence generation strategies.
Regulatory agencies, payers, and the scientific community are all encouraging: pharma sponsors to implement strategies that leverage established registry data to support real-world evidence (RWE) generation for new and established treatments.
Download this guidebook coauthored by Informa and UBC’s scientific and commercialization experts to learn about:
- Tailoring evidence generation strategies to obtain a more holistic picture of the patient
- The importance of data interoperability
- How real-world infrastructure can be used to uncover critical insights